Precision’s trial expertise for small- to medium-sized biopharma covers a range of therapeutic areas and modalities, with broad global reach to access larger, treatment naïve populations. With a reputation for rapid execution and superb project management, Precision aims to be the partner of choice for study expansion or rescue studies.
Services include end-to-end trial execution, including site activation and enrollment, regulatory services, data management, central labs, medical monitoring, QA/site audits and training for the site teams. Therapeutic area coverage includes Oncology, CNS, Dermatology, Infectious Disease and Rare/Orphan indications.
Moreover, across all regions, the Precision team is particularly experienced in working with advanced therapeutics such as stem cells, which requires careful management of regulatory interactions to ensure successful site approvals.
Fully Integrated with broader Precision services
Precision’s global trial implementation also come fully integrated with the rest of its world class services to support biomarker-driven drug development programs. This includes a full range of in-house specialty assays [link to global biomarker assay tile/page] and one of the industry’s most unique platforms for managing and analyzing complex biomarker data in early development, QuartzBioSM.